FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:530-532 February 22, 1996 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Although allergen immunotherapy has been used to treat allergic asthma for over 70 years, its role remains controversial. The consensus report on diagnosis and management of asthma of the National Institutes of Health recommends that allergen immunotherapy should be considered only when asthma is poorly controlled with drug therapy or when it is impossible to avoid allergens,¹ whereas the British Thoracic Society Guidelines do not recommend immunotherapy under any circumstances.² There have been many trials of immunotherapy, but the results are often difficult to interpret because of the use of allergen extracts that are not standardized, poor study design, and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.